英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Andarine/S-4 |
SARM S4 |
401900-40-1 |
詳細(xì)
|
YK11 |
YK11 |
431579-34-9 |
詳細(xì)
|
Ibutamoren mesylate/MK677 |
伊布莫侖甲磺酸鹽 |
159752-10-0 |
詳細(xì)
|
LGD3033 |
LGD-3303 |
917891-35-1 |
詳細(xì)
|
SR9009 |
SR9009 |
1379686-30-2 |
詳細(xì)
|
Vosilasarm/RAD140 |
RAD-140 |
1182367-47-0 |
詳細(xì)
|
Cetuximab |
西妥昔單抗 |
205923-56-4 |
詳細(xì)
|
LGD4033 |
LGD4033 |
1165910-22-4 |
詳細(xì)
|
Maribavir |
苯并咪唑核苷 |
176161-24-3 |
詳細(xì)
|
Acadesine |
阿卡地新 |
2627-69-2 |
詳細(xì)
|
Cardarine/GW501516 |
GW501516 |
317318-70-0 |
詳細(xì)
|
Enobosarm/MK2866 |
OSTARINE(MK-2866) |
841205-47-8 |
詳細(xì)
|
Infliximab |
英夫利昔單抗 |
170277-31-3 |
詳細(xì)
|
Lumiliximab |
LUMILIXIMAB ( 魯昔單抗 ) |
357613-86-6 |
詳細(xì)
|
Galiximab |
加利昔單抗 |
357613-77-5 |
詳細(xì)
|
Research Grade Priliximab |
普立昔單抗 |
147191-91-1 |
詳細(xì)
|
Ganitumab |
GANITUMAB ( 加尼妥單抗 ) |
905703-97-1 |
詳細(xì)
|
Bertilimumab |
柏替木單抗 |
375348-49-5 |
詳細(xì)
|
Briakinumab |
布雷奴單抗 |
339308-60-0 |
詳細(xì)
|
Tralokinumab |
曲羅蘆單抗 |
1044515-88-9 |
詳細(xì)
|
Adecatumumab |
阿德木單抗 |
503605-66-1 |
詳細(xì)
|
Tuvirumab |
Tuvirumab |
138660-97-6 |
詳細(xì)
|
Oportuzumab Monatox |
Oportuzumab Monatox |
945228-48-8 |
詳細(xì)
|
Tremelimumab |
CTLA-4 單抗 |
745013-59-6 |
詳細(xì)
|
Tucotuzumab Celmoleukin |
Tucotuzumab Celmoleukin |
339986-90-2 |
詳細(xì)
|
Etaracizumab |
伊瑞西珠 |
892553-42-3 |
詳細(xì)
|
Iratumumab |
伊妥木單抗 |
640735-09-7 |
詳細(xì)
|
Volociximab |
Volociximab |
558480-40-3 |
詳細(xì)
|
notuzumab |
奧英妥珠單抗 |
635715-01-4 |
詳細(xì)
|
Bapineuzumab |
bapineuzumab |
648895-38-9 |
詳細(xì)
|
Panobacumab |
PANOBACUMAB ( 帕巴庫單抗 ) |
885053-97-4 |
詳細(xì)
|
Otelixizumab |
OTELIXIZUMAB ( 奧昔組單抗 ) |
881191-44-2 |
詳細(xì)
|
Obinutuzumab |
阿托珠單抗 |
949142-50-1 |
詳細(xì)
|
Denosumab |
迪諾蘇單抗 |
615258-40-7 |
詳細(xì)
|
Yttrium (90Y) Tacatuzumab Tetraxetan |
Yttrium (90Y) Tacatuzumab Tetraxetan |
476413-07-7 |
詳細(xì)
|
Raxibacumab |
瑞西巴庫 |
565451-13-0 |
詳細(xì)
|
Canakinumab |
卡那津單抗 |
914613-48-2 |
詳細(xì)
|
Citatuzumab Bogatox |
Citatuzumab Bogatox |
945228-49-9 |
詳細(xì)
|
Besilesomab |
Besilesomab |
537694-98-7 |
詳細(xì)
|
Epitumomab |
索土珠單抗 |
372075-37-1 |
詳細(xì)
|
Ibalizumab |
伊巴組單抗 |
680188-33-4 |
詳細(xì)
|
Alacizumab |
培戈-阿拉賽珠單抗 |
934216-54-3 |
詳細(xì)
|
Fresolimumab |
非蘇木單抗 |
948564-73-6 |
詳細(xì)
|
Ustekinumab |
烏司奴單抗 |
815610-63-0 |
詳細(xì)
|
Mapatumumab |
Mapatumumab |
658052-09-6 |
詳細(xì)
|
ofatumumab |
奧法木單抗 |
679818-59-8 |
詳細(xì)
|
Ertumaxomab |
ertumaxomab |
509077-99-0 |
詳細(xì)
|
Ipilimumab |
伊匹單抗 |
477202-00-9 |
詳細(xì)
|
Metelimumab |
Meterelin |
272780-74-2 |
詳細(xì)
|
Regavirumab |
瑞加韋單抗 |
153101-26-9 |
詳細(xì)
|
Conatumumab |
西他土珠 |
896731-82-1 |
詳細(xì)
|
Research Grade Lerdelimumab |
樂德木單抗 |
285985-06-0 |
詳細(xì)
|
Stamulumab |
司他莫魯 |
705287-60-1 |
詳細(xì)
|
Zanolimumab |
ZanoliMuMab |
652153-01-0 |
詳細(xì)
|
Tenatumomab |
TENATUMOMAB ( 替妥莫單抗 ) |
1412891-40-7 |
詳細(xì)
|
Anrukinzumab |
ANRUKINZUMAB ( 安蘆組單抗 ) |
910649-32-0 |
詳細(xì)
|
Research Grade Camidanlumab |
卡利尤單抗 |
921618-45-3 |
詳細(xì)
|
Tigatuzumab |
TIGATUZUMAB ( 替加組單抗 ) |
918127-53-4 |
詳細(xì)
|
Efungumab |
依芬古單抗 |
762260-74-2 |
詳細(xì)
|
Research Grade Golimumab |
戈利木單抗 |
476181-74-5 |
詳細(xì)
|
ocrelizumab |
Ocrelizumab |
637334-45-3 |
詳細(xì)
|
Research Grade Otilimab |
對(duì)照抗體 |
1638332-55-4 |
詳細(xì)
|
Zalutumumab |
扎蘆木單抗 |
667901-13-5 |
詳細(xì)
|
Racotumomab |
RACOTUMOMAB ( 雷妥莫單抗 ) |
946832-34-4 |
詳細(xì)
|
Lexatumumab |
來沙木單抗 |
845816-02-6 |
詳細(xì)
|
Catumaxomab |
catumaxomab |
509077-98-9 |
詳細(xì)
|
Research Grade HuCC49 |
|
823788-82-5 |
詳細(xì)
|
Panitumumab |
帕尼單抗 |
339177-26-3 |
詳細(xì)
|
Gantenerumab |
更汀蘆單抗 |
1043556-46-2 |
詳細(xì)
|
Tanezumab |
他尼珠 |
880266-57-9 |
詳細(xì)
|
Dacetuzumab |
達(dá)西組單抗 |
880486-59-9 |
詳細(xì)
|
Ecromeximab |
Kw-2871 |
292819-64-8 |
詳細(xì)
|
reslizumab |
RESLIZUMAB |
241473-69-8 |
詳細(xì)
|
Pritumumab |
普托木單抗 |
499212-74-7 |
詳細(xì)
|
Tefibazumab |
Tefibazumab |
521079-87-8 |
詳細(xì)
|
Libivirumab |
LIBIVIRUMAB ( 利韋單抗 ) |
569658-79-3 |
詳細(xì)
|
Belimumab |
貝利木單抗 |
356547-88-1 |
詳細(xì)
|
Exbivirumab |
EXBIVIRUMAB ( 艾韋單抗 ) |
569658-80-6 |
詳細(xì)
|
Elsilimomab |
伊斯利莫 |
468715-71-1 |
詳細(xì)
|
Urtoxazumab |
URTOXAZUMAB ( 烏珠單抗 ) |
502496-16-4 |
詳細(xì)
|
Teneliximab |
阿塞珠單抗 |
395639-53-9 |
詳細(xì)
|
Erlizumab |
厄利珠單抗 |
211323-03-4 |
詳細(xì)
|
Vapaliximab |
VAPALIXIMAB ( 伐利昔單抗 ) |
336801-86-6 |
詳細(xì)
|
Cixutumumab |
CIXUTUMUMAB ( 西妥木單抗 ) |
947687-12-9 |
詳細(xì)
|
Lemalesomab |
Immunoglobulin G1,anti-(human NCA-90 granulocyte cell antigen) (mouse monoclonal IMMU-MN3 g1-chain), disulfide with mousemonoclonal IMMU-MN3 k-chain, dimer (9CI) |
250242-54-7 |
詳細(xì)
|
Farletuzuma |
FARLETUZUMAB ( 法妥組單抗 ) |
896723-44-7 |
詳細(xì)
|
Research Grade Bivatuzumab |
|
|
詳細(xì)
|
Research Grade Pintumomab |
|
|
詳細(xì)
|
SU5408 |
VEGFR2 KISE INHIBITOR I |
15966-93-5 |
詳細(xì)
|
Robatumumab |
ROBATUMUMAB ( 羅妥木單抗 ) |
934235-44-6 |
詳細(xì)
|
Elotuzumab |
埃羅妥珠單抗 |
915296-00-3 |
詳細(xì)
|
Research Grade Anatumomab |
|
|
詳細(xì)
|
Research Grade Sibrotuzumab |
|
|
詳細(xì)
|
Figitumumab |
FIGITUMUMAB ( 芬妥木單抗 ) |
943453-46-1 |
詳細(xì)
|
Nebacumab |
奈巴庫單抗 |
138661-01-5 |
詳細(xì)
|
Research Grade J695 |
|
|
詳細(xì)
|
Keliximab |
凱利昔單抗 |
174722-30-6 |
詳細(xì)
|
Research Grade Clenoliximab |
clenoliximab |
182912-58-9 |
詳細(xì)
|
Research Grade Taplitumomab |
|
|
詳細(xì)
|
Pagibaximab |
帕吉昔單抗 |
595566-61-3 |
詳細(xì)
|